These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 9046687)
1. The role of azole antifungal agents for systemic antifungal therapy. Lee YP; Goldman M Cleve Clin J Med; 1997 Feb; 64(2):99-106. PubMed ID: 9046687 [TBL] [Abstract][Full Text] [Related]
2. Systemic antifungal drugs. Med Lett Drugs Ther; 1994 Feb; 36(916):16-8. PubMed ID: 8302208 [No Abstract] [Full Text] [Related]
3. Antifungal therapy: potential interactions with other classes of drugs. Bickers DR J Am Acad Dermatol; 1994 Sep; 31(3 Pt 2):S87-90. PubMed ID: 8077516 [TBL] [Abstract][Full Text] [Related]
4. Systemic antifungal drugs. Med Lett Drugs Ther; 1996 Feb; 38(967):10-2. PubMed ID: 8559113 [No Abstract] [Full Text] [Related]
6. The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients. Paterson PJ; McWhinney PH; Potter M; Kibbler CC; Prentice HG Br J Haematol; 2001 Jan; 112(1):175-80. PubMed ID: 11167799 [TBL] [Abstract][Full Text] [Related]
7. Recent advances in the treatment of systemic fungal infections. Walsh TJ Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615 [TBL] [Abstract][Full Text] [Related]
8. Drugs for treatment of fungal infections. Med Lett Drugs Ther; 1992 Feb; 34(864):14-6. PubMed ID: 1310518 [No Abstract] [Full Text] [Related]
9. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Almyroudis NG; Sutton DA; Fothergill AW; Rinaldi MG; Kusne S Antimicrob Agents Chemother; 2007 Jul; 51(7):2587-90. PubMed ID: 17452481 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection. Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963 [TBL] [Abstract][Full Text] [Related]
11. Use of azoles for systemic antifungal therapy. Kauffman CA; Carver PL Adv Pharmacol; 1997; 39():143-89. PubMed ID: 9160115 [No Abstract] [Full Text] [Related]
12. [Commonly used antifungal agents in the treatment of systemic mycoses]. Berenguer Berenguer J Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308 [No Abstract] [Full Text] [Related]
13. Oral azole drugs as systemic antifungal therapy. Como JA; Dismukes WE N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088 [TBL] [Abstract][Full Text] [Related]
14. Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis. Ellepola AN; Samaranayake LP Dent Update; 2000 May; 27(4):165-70, 172-4. PubMed ID: 11218451 [TBL] [Abstract][Full Text] [Related]
15. Azole drug resistance in yeasts. Johnson EM; Warnock DW J Antimicrob Chemother; 1995 Nov; 36(5):751-5. PubMed ID: 8626255 [No Abstract] [Full Text] [Related]
17. Outpatient therapy of HIV-associated oral and oesophageal candidosis. Ustianowski AP; Leake H; Evans S Int J STD AIDS; 1997 Sep; 8(9):592-4. PubMed ID: 9292351 [No Abstract] [Full Text] [Related]
18. A brief review of antifungal therapy for deep fungal infection. Muller RJ Oncology (Williston Park); 2001 Nov; 15(11 Suppl 9):21-5. PubMed ID: 11757847 [TBL] [Abstract][Full Text] [Related]
19. An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals. Hector RF Clin Tech Small Anim Pract; 2005 Nov; 20(4):240-9. PubMed ID: 16317914 [TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy of disseminated histoplasmosis in patients with AIDS. Drew RH Ann Pharmacother; 1993 Dec; 27(12):1510-8. PubMed ID: 8305787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]